New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 2, 2013
08:23 EDTABTAbbott shares attractive following spin-off, says Wells Fargo
After Abbott spun off its proprietary pharmaceuticals business, Wells Fargo believes the new Abbott's stock is attractive, partly due to what the firm sees as the company's above-average top- and bottom-line growth outlook and significant margin expansion opportunities. The firm lowered its valuation range for the stock to $33-$34 from $71-$74 to reflect the spin-off, and maintains an Outperform rating on the shares.
News For ABT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 21, 2015
07:37 EDTABTPfizer replaces AbbVie as top global pharma pick at Jefferies
Subscribe for More Information
May 19, 2015
08:02 EDTABTAbbott announces CE Mark for new advancement of Absorb stent system
Subscribe for More Information
May 18, 2015
11:23 EDTABTFitch downgrades Abbott's L-T IDR to A; outlook revised to stable
Subscribe for More Information
May 14, 2015
09:41 EDTABTLeerink medical devices analyst holds a cardiology luncheon meeting
Subscribe for More Information
May 11, 2015
10:30 EDTABTAbbott names Brian Yoor as SVP, Finance and CFO
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use